DBV Technologies (DBVT) Cash from Operations (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Cash from Operations of 52600000.0 for Q2 2026, down 55.16% year-on-year from 117311842.11 in Q2 2025, and down 7.13% on a QoQ basis from 49100000.0 in Q1 2026.

DBV Technologies (DBVT) Cash from Operations (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Cash from Operations for 7 consecutive years, with 52600000.0 the latest figure, recorded in Q2 2026.

  • Quarterly Cash from Operations fell 55.16% year-over-year to 52600000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 169281000.0 (down 91.69% YoY) and the FY2025 annual result came in at 121181000.0, down 15.99% from the prior year.
  • Cash from Operations fell to 52600000.0 in Q2 2026 per DBVT's latest filing, from 49100000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for DBVT reached as high as 1483000.0 in Q1 2022 and fell as low as 52600000.0 in Q2 2026.
  • A 5-year average of 25704111.11 and a median of 23171000.0 in 2022 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2022 — Cash from Operations soared 95.9% — and 2023, when it slumped 1305.33%.
  • Year by year, Cash from Operations stood at 23885000.0 in 2022, then surged by 42.7% to 13686000.0 in 2023, then gained by 10.48% to 12252000.0 in 2024, then tumbled by 187.08% to 35173000.0 in 2025, then sank by 49.55% to 52600000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 52600000.0, 49100000.0, and 35173000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.59 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 201.34 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.17 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - -52.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.60 Mn
Jun 30, 2026 -52.60 Mn
Mar 31, 2026 -49.10 Mn
Mar 31, 2026 -49.10 Mn
Dec 31, 2025 -35.17 Mn
Dec 31, 2025 -35.17 Mn
Sep 30, 2025 -32.41 Mn
Sep 30, 2025 -32.41 Mn
Jun 30, 2025 -33.90 Mn
Jun 30, 2025 -33.90 Mn
Mar 31, 2025 -19.70 Mn
Mar 31, 2025 -19.70 Mn
Dec 31, 2024 -12.25 Mn
Dec 31, 2024 -12.25 Mn
Sep 30, 2024 -22.46 Mn
Sep 30, 2024 -22.46 Mn
Jun 30, 2024 -35.07 Mn
Jun 30, 2024 -35.07 Mn
Mar 31, 2024 -34.69 Mn
Mar 31, 2024 -34.69 Mn